Discusses various aspects related to steroid-sparing drugs for dermatologists in the United States. Benefits of using steroid-sparing drugs; Maximum amount of time for steroid use before onset of side effects; St...
例句 释义: 全部 更多例句筛选 1. Corticosteroids, as drugs of first choice, often must be combined with steroid-sparing agents to prevent hazardous long-term side effects. 皮质类固醇,作为首选药物,通常必须结合类固醇保留剂,以防止危险的长期副作用。 www.syyxw.com©...
A drug that is used to treat rheumatoid arthritis and acts more slowly but more effectively than nonsteroidal anti-inflammatory drugs. Such drugs include hydroxychloroquine, methotrexate, and tumor necrosis factor inhibitors. Synonym: slow-acting antirheumatic drug See also: drug Medical Dictionary, ...
网络节约类固醇 网络释义 1. 节约类固醇 Nelson等[19]报道TAO能改变甲基强的松龙代谢而起着“节约类固醇”(steroid-sparing)作用。有的作者在使用大环内酯类抗生 … www.jcys120.com|基于4个网页
Dr,Kazunari,Tanabe - 《Drugs》 被引量: 118发表: 2003年 Steroid or Calcineurin Inhibitor-Sparing Immunosuppressive Protocols Steroids have accompanied other immunosuppressants throughout the history of renal transplantation. However, its permanent use has been associated with a m... JM Grinyó,JM Cruz...
In the treatment of chronic sarcoidosis refractory to steroid, methotrexate and other immunosuppresive drugs have been reported as the steroid sparing altetrnatives. The issue is reviwed on the basis of Baughman's special lecture entitled "New treament of sarcoidosis", performed at the 18th annual...
Traditionally, such treatments have been used off label by ophthalmologists, but that is slowly changing, with recent FDA approvals for drugs such as adalimumab. Th e use of steroid-sparing therapy can improve patient lives signifi cantly, off ering the potential to consistently manage ocular ...
Drugs that may cause or exacerbate heart failure: a scientific statement from the American Heart Association [published correction appears in Circulation. 2016;134(12):e261]. Circulation. 2016;134(6):e32-e69. PubMedGoogle ScholarCrossref 35. Baldassano RN. Infliximab in pediatric Crohn...
With the efficiency of research and development of new drugs in the United States halving approximately every 9 years (Eroom's law), the unmet medical gap for management of these rare disorders continues to widen.14 Drug repositioning represents an economically viable path to develop new ...
It is FDA approved for the treatment of rheumatoid arthritis in cases of inadequate response to other disease modifying anti-rheumatic drugs. Prior in-vitro studies have demonstrated that activation of the TSH receptor induces expression of the pro-inflammatory cytokine IL-6 in orbital fibroblasts. ...